QUALIGEN THERAPEUTICS INC (QLGN)
US74754R2022 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -13.76M | -21.03M | -17.90M | -19.55M | -10.13M | |||
| Depreciation Amortization | 4.50K | 150.00K | 110.00K | 90.00K | 10.00K | |||
| Change In Working Capital | 1.11M | -50.00K | 1.85M | -2.98M | -4.34M | |||
| Interest Paid | N/A | 0.00 | 0.00 | 30.00K | N/A | |||
| Taxes Paid | 5.57K | 10.00K | 10.00K | 0.00 | 190.00K | |||
| Other non cash items | 2.34M | 7.68M | 1.20M | 12.28M | -50.00K | |||
| OPERATING CASH FLOW | -10.30M | -13.25M | -14.73M | -10.16M | -14.52M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -320.00K | -140.00K | -210.00K | 0.00 | |||
| Other Investing Activity | 4.22M | 140.00K | N/A | 150.00K | 7.00M | |||
| INVESTING CASH FLOW | 4.22M | -180.00K | -140.00K | -70.00K | 7.00M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -550.00K | 0.00 | -140.00K | 70.00K | N/A | |||
| Stock Issued/Repurchased | N/A | 10.00K | 9.28M | 35.34M | 1.46M | |||
| Other Financing Activity | N/A | 2.90M | -710.00K | -1.36M | -50.00K | |||
| FINANCING CASH FLOW | -550.00K | 2.91M | 8.43M | 34.05M | 1.41M | |||
| Exchange Rate Effect | N/A | 20.00K | N/A | N/A | N/A | |||
| CHANGE IN CASH | -6.64M | -10.50M | -6.44M | 23.82M | -6.11M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -10.30M | -13.25M | -14.73M | -10.16M | -14.52M | |||
| Capital Expenditure | N/A | -320.00K | -140.00K | -210.00K | 0.00 | |||
| FREE CASH FLOW | -10.30M | -13.57M | -14.87M | -10.37M | -14.52M | |||
All data in USD